Patents Assigned to Biotech Institute LLC
-
Patent number: 11528861Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty Cannabis.Type: GrantFiled: October 27, 2017Date of Patent: December 20, 2022Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
-
Patent number: 11432488Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘05.09.24.S1’. The present disclosure relates to seeds of the hemp plant ‘05.09.24.S1,’ to plants and parts of the hemp plant ‘05.09.24.S1,’ and to methods for producing a hemp plant by crossing the hemp plant ‘05.09.24.S1’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.Type: GrantFiled: May 24, 2021Date of Patent: September 6, 2022Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: 11317577Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘095101’. The present disclosure relates to seeds of the hemp plant ‘095101,’ to plants and parts of the hemp plant ‘095101,’ and to methods for producing a hemp plant by crossing the hemp plant ‘095101’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.Type: GrantFiled: May 24, 2021Date of Patent: May 3, 2022Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: 10830780Abstract: The disclosure relates to systems, apparatuses, and methods for estimating a terpene level of two or more terpenes of the plurality of terpenes in the sample to generate a set of terpene levels; and/or estimating a cannabinoid level of two or more cannabinoids of the plurality of cannabinoids in the sample to generate a set of cannabinoid levels; configured to store a set of groups and classify the sample to a group of the set of groups, based on said terpene and cannabinoid levels. The present disclosure also relates to systems, apparatuses, and methods configured to generate entourage effect values and organoleptic values, based on said cannabinoid and terpene levels.Type: GrantFiled: January 27, 2016Date of Patent: November 10, 2020Assignee: Biotech Institute, LLCInventors: Matthew W. Giese, Mark Anthony Lewis
-
Patent number: 10582676Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.Type: GrantFiled: June 17, 2015Date of Patent: March 10, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
-
Patent number: 10502750Abstract: The present invention teaches methods useful for accurately and precisely analyzing cannabis plants, plant parts, and extract samples. In particular, the present invention teaches methods of extracting, and quantifying cannabinoid and terpene constituents.Type: GrantFiled: December 23, 2015Date of Patent: December 10, 2019Assignee: Biotech Institute, LLCInventors: Matthew W. Giese, Mark Anthony Lewis, Laura Giese
-
Patent number: 10441617Abstract: The invention provides compositions and methods for the breeding, production, processing and use of medical cannabis.Type: GrantFiled: March 17, 2014Date of Patent: October 15, 2019Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Michael Dane Backes
-
Patent number: 9642317Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.Type: GrantFiled: May 11, 2016Date of Patent: May 9, 2017Assignee: Biotech Institute, LLC.Inventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
-
Patent number: 9370164Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty Cannabis.Type: GrantFiled: June 17, 2015Date of Patent: June 21, 2016Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
-
Patent number: 9095554Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.Type: GrantFiled: March 17, 2014Date of Patent: August 4, 2015Assignee: Biotech Institute LLCInventors: Mark Anthony Lewis, Michael D Backes, Matthew Giese
-
Patent number: PP31535Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘LEMON CRUSH OG’. The main terpenes found in ‘LEMON CRUSH OG’ are limoene, beta-caryophyllene, alpha-humulene, linalool, trans-ocimene, beta-pinene, fenchol, alpha-terpineol, alpha-pinene and myrcene. The estimated concentration of the total THCmax, CBDmax, and CBGmax is about 18.77-23.19%, about 0%, and about 0.98-1.78%, respectively, at the time of assaying metabolites from flower samples of ‘LEMON CRUSH OG’. Harvest interval, i.e. at 56-70 days under short day conditions.Type: GrantFiled: March 16, 2018Date of Patent: March 10, 2020Assignee: Biotech Institute LLCInventors: Mark A. Lewis, Steven Haba
-
Patent number: PP31707Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘GRAPE LOLIPOP’. Disclosed herein are main terpenes of ‘GRAPE LOLIPOP’, which are myrcene, limonene, beta-caryophyllene, alpha-pinene, alpha-humulene, beta-pinene, and linalool. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 3.09-7.59%, about 9.97-16.68% and about 0.21-0.70% respectively, at the time of assaying metabolites from flower samples of ‘GRAPE LOLIPOP’.Type: GrantFiled: August 28, 2018Date of Patent: April 28, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP31724Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘PRIMO CHERRY’. Disclosed herein are main terpenes of ‘PRIMO CHERRY’, which are myrcene, alpha-pinene, hexyl butyrate, beta-pinene, limonene, and linalool. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 12.38-15.24%, about 5.40-7.13%, and about 0.22-0.33%, respectively, at the time of assaying metabolites from flower samples of ‘PRIMO CHERRY’.Type: GrantFiled: August 28, 2018Date of Patent: May 5, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP31752Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘CAKE BATTER COOKIES’. Disclosed herein are main terpenes of ‘CAKE BATTER COOKIES’, which are limonene, beta-caryophyllene, beta-pinene, linalool, alpha-humulene, alpha-pinene, fenchol, myrcene, alpha-bisabolol, and alpha-terpineol. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 6.5-14.21%, about 5.36-9.82%, and about 0.11-0.42%, respectively, at the time of assaying metabolites from flower samples of ‘CAKE BATTER COOKIES’.Type: GrantFiled: August 1, 2018Date of Patent: May 12, 2020Assignee: Biotech Institute, LLCInventors: Mark A. Lewis, Steven Haba
-
Patent number: PP31874Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘HOLY CRUNCH’. Disclosed herein are main terpenes of ‘HOLY CRUNCH’, which are beta-caryophyllene, limonene, myrcene, linalool, alpha-humulene, trans-ocimene, alpha-bisabolol, and alpha-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 6.56-16.74%, about 6.49-15.28%, and about 0.25-1.87%, respectively, at the time of assaying metabolites from flower samples of ‘HOLY CRUNCH’.Type: GrantFiled: August 28, 2018Date of Patent: June 16, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP31917Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘RASPBERRY PUNCH’. Disclosed herein are main terpenes of ‘RASPBERRY PUNCH,’ which are limonene, myrcene, beta-caryophyllene, linalool, alpha-humulene, alpha-bisabolol, and beta-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 4.94-8.64%, about 12.04-17.74%, and about 0.59-1.01%, respectively, at the time of assaying metabolites from flower samples of ‘RASPBERRY PUNCH’.Type: GrantFiled: November 5, 2018Date of Patent: June 30, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP31918Abstract: The present invention provides a new and distinct Cannabis cultivar designated as ‘RAINBOW GUMMEEZ.’ Disclosed herein are main terpenes of ‘RAINBOW GUMMEEZ’ which are terpinolene, myreene, alpha-pinene, alpha-terpineol, trans-ocimene, beta-pinene, and beta caryophyllene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax and CBGmax, about 4.37-7.87%, about 5.18-9.48%, and about 0.14-0.60%, respectively, at the time of assaying metabolites from flower samples of ‘RAINBOW GUMMEEZ.Type: GrantFiled: August 28, 2018Date of Patent: June 30, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP32473Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘BIHEMP 050924.’ Disclosed herein are main terpenes of ‘BIHEMP 050924,’ which are beta-caryophyllene, limonene, alpha-humulene, linalool, myrcene, trans-ocimene, beta-pinene, fenchol, and alpha-terpineol. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 0.21-0.43%, about 5.02-10.86%, and about 0.10-0.72%, respectively, at the time of assaying metabolites from flower samples of ‘BIHEMP 050924.Type: GrantFiled: August 28, 2018Date of Patent: November 17, 2020Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP33000Abstract: Disclosed herein are main terpenes of ‘OG CITRON’, which are linalool, limonene, myrcene, beta-caryophyllene, alpha-bisabolol, alpha-humulene, and beta-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 9.90-12.66%, about 5.50-9.23%, and about 0.08-0.78%, respectively, at the time of assaying metabolites from flower samples of ‘OG CITRON’.Type: GrantFiled: April 17, 2019Date of Patent: April 27, 2021Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba
-
Patent number: PP33332Abstract: The present invention provides new and distinct Cannabis cultivars designated as ‘HAPPY PINEAPPLE’. Disclosed herein are main terpenes of ‘HAPPY PINEAPPLE’, which are beta-ocimene, beta-caryophyllene, alpha-pinene, limonene, alpha-humulene, beta-pinene and myrcene. Also, the present invention provides the estimated concentration of the THCmax about 14.50-18.57% and CBDmax about 0.00%, respectively, at the time of assaying metabolites from flower samples of ‘HAPPY PINEAPPLE’.Type: GrantFiled: December 16, 2019Date of Patent: August 10, 2021Assignee: Biotech Institute, LLCInventors: Mark Anthony Lewis, Steven Robert Haba